Δ9-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18

Microglial cells are extremely plastic and undergo a variety of CNS-prompted shape changes relative to their location and current role. Signaling molecules from neurons also regulate microglial cytokine production. Neurons are known to employ the endogenous cannabinoid system to communicate with other cells of the CNS. N-arachidonoyl glycine (NAGly) and Δ9-tetrahydrocannabinol (Δ9-THC) signaling via GPR18 has been introduced as an important new target in microglial–neuronal communication. Our hypothesis is that endogenous NAGly-GPR18 signaling regulates phenotypic shape and cytokine production in microglia, and is mimicked by Δ9-THC in the BV-2 microglia model system. BV-2 microglia were exposed to NAGly and Δ9-THC or Vh for 12 h, which resulted in significant differences in the cell morphologies expressed. Cannabidiol (CBD) was effective at antagonizing the effects of both NAGly and Δ9-THC. Using ELISA-based microarrays, BV-2 microglia were exposed to NAGly and Δ9-THC or Vh for 3 h and the presence of 40 cytokines in the culture media quantified. Production of Axl, CD40, IGF-I, OPN, and Pro-MMP-9 were significantly altered by NAGly and Δ9-THC, and antagonized by CBD. These data add to an emerging profile that emphasizes NAGly as a component of an endogenous system present in the CNS that tightly integrates microglial proliferation, recruitment, and adhesion with neuron–glia interactivity and tissue remodeling.

[1]  Clinton Scoltard.  The Pathway , 1899 .

[2]  F. Bistoni,et al.  Immortalization of murine microglial cells by a v-raf / v-myc carrying retrovirus , 1990, Journal of Neuroimmunology.

[3]  D. Clemmons,et al.  Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.

[4]  M. Mark,et al.  Characterization of Gas6, a Member of the Superfamily of G Domain-containing Proteins, as a Ligand for Rse and Axl (*) , 1996, The Journal of Biological Chemistry.

[5]  V. Kähäri,et al.  Matrix metalloproteinases in skin , 1997, Experimental dermatology.

[6]  L. Samuelson,et al.  Cloning and chromosomal localization of a gene (GPR18) encoding a novel seven transmembrane receptor highly expressed in spleen and testis. , 1997, Genomics.

[7]  B. Wittig,et al.  Regulation and possible function of axl expression in immature human mast cells , 1998, Annals of Hematology.

[8]  T. Bonner,et al.  Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Testa,et al.  Cloning and chromosomal localization of a gene encoding a novel serine/threonine kinase belonging to the subfamily of testis-specific kinases. , 2001, Genomics.

[10]  M. Carson.  Microglia as liaisons between the immune and central nervous systems: Functional implications for multiple sclerosis , 2002, Glia.

[11]  R. Flavell,et al.  Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice , 2002, Nature Neuroscience.

[12]  T. Kipari,et al.  Osteopontin--a molecule for all seasons. , 2002, QJM : monthly journal of the Association of Physicians.

[13]  R. Veerhuis,et al.  Neuroinflammation in Alzheimer's disease and prion disease , 2002, Glia.

[14]  W. Streit.  Microglia as neuroprotective, immunocompetent cells of the CNS , 2002, Glia.

[15]  M. Bernardo,et al.  Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes. , 2003, Biochemical and biophysical research communications.

[16]  K. Mackie,et al.  Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration , 2003, The Journal of Neuroscience.

[17]  W. Dietrich,et al.  Inflammatory Mechanisms after Ischemia and Stroke , 2003, Journal of neuropathology and experimental neurology.

[18]  C. Geula,et al.  Neurotrophins regulate proliferation and survival of two microglial cell lines in vitro , 2003, Experimental Neurology.

[19]  S. Gordon.  Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[20]  G. Raivich.  Like cops on the beat: the active role of resting microglia , 2005, Trends in Neurosciences.

[21]  D. Osei-Hyiaman,et al.  Evidence for novel cannabinoid receptors. , 2005, Pharmacology & therapeutics.

[22]  L. Fetler,et al.  Neuroscience. Brain under surveillance: the microglia patrol. , 2005, Science.

[23]  S. Tsirka,et al.  Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage. , 2005, Brain : a journal of neurology.

[24]  L. Fetler,et al.  Brain Under Surveillance: The Microglia Patrol , 2005, Science.

[25]  H. Kerschbaum,et al.  An artificial three-dimensional matrix promotes ramification in the microglial cell-line, BV-2 , 2006, Neuroscience Letters.

[26]  K. Mackie,et al.  Cannabinoid receptors and endocannabinoids , 2006 .

[27]  Atsushi Inoue,et al.  Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18. , 2006, Biochemical and biophysical research communications.

[28]  T. Möller,et al.  Microglia Biology in Health and Disease , 2006, Journal of Neuroimmune Pharmacology.

[29]  M. Block,et al.  Microglia-mediated neurotoxicity: uncovering the molecular mechanisms , 2007, Nature Reviews Neuroscience.

[30]  K. Mackie,et al.  Cannabinoid receptors and endocannabinoids: Evidence for new players , 2006, The AAPS Journal.

[31]  Min Goo Lee,et al.  Identification of Farnesyl Pyrophosphate and N-Arachidonylglycine as Endogenous Ligands for GPR92* , 2008, Journal of Biological Chemistry.

[32]  C. D. Palmer,et al.  Critical role of microglial CD40 in the maintenance of mechanical hypersensitivity in a murine model of neuropathic pain , 2009, European journal of immunology.

[33]  H. Bradshaw,et al.  The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways , 2009, BMC Biochemistry.

[34]  Z. Vogel,et al.  N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor , 2010, BMC Neuroscience.

[35]  D. Leroith,et al.  The pathway from diabetes and obesity to cancer, on the route to targeted therapy. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[36]  Stephen P. H. Alexander,et al.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 , 2010, Pharmacological Reviews.

[37]  Ania K. Majewska,et al.  Microglial Interactions with Synapses Are Modulated by Visual Experience , 2010, PLoS biology.

[38]  C. Colton,et al.  Assessing activation states in microglia. , 2010, CNS & neurological disorders drug targets.

[39]  R. Leurs,et al.  Quantitative expression profiling of G‐protein‐coupled receptors (GPCRs) in metastatic melanoma: the constitutively active orphan GPCR GPR18 as novel drug target , 2011, Pigment cell & melanoma research.

[40]  W. Wong,et al.  Microglial Morphology and Dynamic Behavior Is Regulated by Ionotropic Glutamatergic and GABAergic Neurotransmission , 2011, PloS one.

[41]  G. Castellano,et al.  Human cutaneous melanomas lacking MITF and melanocyte differentiation antigens express a functional Axl receptor kinase. , 2011, The Journal of investigative dermatology.

[42]  D. McHugh,et al.  GPR18 in microglia: implications for the CNS and endocannabinoid system signalling , 2012, British journal of pharmacology.

[43]  M. Ishii,et al.  Layer V cortical neurons require microglial support for survival during postnatal development , 2013, Nature Neuroscience.

[44]  L. Wollmuth,et al.  Microglia Actively Regulate the Number of Functional Synapses , 2013, PloS one.

[45]  A. Mantovani,et al.  International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors , 2014, Pharmacological Reviews.

[46]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.